Literature DB >> 7749115

Engraftment of normal murine marrow into nonmyeloablated host mice.

P J Quesenberry1, H Ramshaw, R B Crittenden, F M Stewart, S Rao, S Peters, P Becker, P Lowry, M Blomberg, J Reilly.   

Abstract

When 200 x 10(6) male BALB/c cells are given by tail vein injection to female nonmyeloablated hosts in one injection, a relatively low engraftment percentage is seen, but when the same total number of cells is given over five injections (separated by 24 hours), the observed engraftment is much higher. A further increase in engraftment appears to occur when the same number of cells is given in 10 injections separated by at least 24 hours. These data suggest that somewhere between 5 and 10% of marrow niches are available at intervals of 24 or more hours and that the keys to high levels of engraftment are the cell cycle status of the engrafting stem cell and the schedule of engraftment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7749115

Source DB:  PubMed          Journal:  Blood Cells        ISSN: 0340-4684


  13 in total

1.  Kidney transplantation with bone marrow augmentation: five-year outcomes.

Authors:  R Shapiro; A S Rao; R J Corry; M Valenti; A Zeevi; M L Jordan; V P Scantlebury; C A Vivas; A Jain; J McCauley; P Randhawa; E A Gray; I Dvorchik; J McMichael; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

Review 2.  Hematopoietic-stem-cell-based gene therapy for HIV disease.

Authors:  Hans-Peter Kiem; Keith R Jerome; Steven G Deeks; Joseph M McCune
Journal:  Cell Stem Cell       Date:  2012-02-03       Impact factor: 24.633

Review 3.  The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases.

Authors:  Irving L Weissman; Judith A Shizuru
Journal:  Blood       Date:  2008-11-01       Impact factor: 22.113

Review 4.  Bone marrow augmentation in renal transplant recipients.

Authors:  R Shapiro; T E Starzl
Journal:  Transplant Proc       Date:  1998-06       Impact factor: 1.066

Review 5.  The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland.

Authors:  Erich Knop; Nadja Knop; Thomas Millar; Hiroto Obata; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 6.  Reduced-intensity conditioned allogeneic SCT in adults with AML.

Authors:  R Reshef; D L Porter
Journal:  Bone Marrow Transplant       Date:  2015-03-02       Impact factor: 5.483

7.  Influence of timing of administration of 5-fluorouracil to donors on bone marrow engraftment in nonmyeloablated hosts.

Authors:  L D'Hondt; J Carlson; B Benoit; J Reilly; C Grimaldi; J Wuu; J F Lambert; M S Dooner; P J Quesenberry
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

8.  Niche recycling through division-independent egress of hematopoietic stem cells.

Authors:  Deepta Bhattacharya; Agnieszka Czechowicz; A G Lisa Ooi; Derrick J Rossi; David Bryder; Irving L Weissman
Journal:  J Exp Med       Date:  2009-11-02       Impact factor: 14.307

9.  Tet2-mediated clonal hematopoiesis in nonconditioned mice accelerates age-associated cardiac dysfunction.

Authors:  Ying Wang; Soichi Sano; Yoshimitsu Yura; Zhonghe Ke; Miho Sano; Kosei Oshima; Hayato Ogawa; Keita Horitani; Kyung-Duk Min; Emiri Miura-Yura; Anupreet Kour; Megan A Evans; Maria A Zuriaga; Karen K Hirschi; Jose J Fuster; Eric M Pietras; Kenneth Walsh
Journal:  JCI Insight       Date:  2020-03-26

10.  Early chimerism threshold predicts sustained engraftment and NK-cell tolerance in prenatal allogeneic chimeras.

Authors:  Emily T Durkin; Kelly A Jones; Deepika Rajesh; Aimen F Shaaban
Journal:  Blood       Date:  2008-09-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.